Yayınlar & Eserler

Yayın Ağı
Makaleler 48
Tümü (48)
SCI-E, SSCI, AHCI (42)
SCI-E, SSCI, AHCI, ESCI (47)
ESCI (1)
Scopus (48)
TRDizin (5)

1. Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides

Naghizade K., Uk E., Aydin M. F., Ozler T. E., EREN N., Ozcan S. G., et al.
BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

2. Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye

Turgutalp K., Ozturk S., Koc N. S., Dolarslan M. E., KOÇYİĞİT İ., TURGUT D., et al.
BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

3. Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy

Kazan S., Öztürk S., Uzerk Kibar M., Ozcan S. G., Alcelik Karacan R. D., EREN N., et al.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

4. Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio

Tunca O., Turkmen A., EREN N., Yadigar S., Karagoz F., DİNÇER M. T., et al.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

5. Association of sleep habits with Alpha-MSH levels in patients with chronic kidney disease

Kandemir T., GÖK M.
BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

6. Predictive Value of CAR for Renal Survival and Mortality in ICU Patients with AKI Requiring Dialysis Valor predictivo de la CAR para la supervivencia y mortalidad renal en pacientes de UCI con IRA que requieren diálisis

Türkoğlu A. K., ŞAHİN G., GÖK M., SALMANOĞLU M., Güney B. Ç., KAPLAN M.
Revista de Nefrologia, Dialisis y Trasplante , cilt.45, sa.1, ss.13-23, 2025 (SCI-Expanded, Scopus)

7. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?

Cetinkaya H., GÜRSU M., Yazici H., CEBECİ E., EREN N., ALTIPARMAK M. R., et al.
Journal of Nephrology , cilt.37, sa.4, ss.923-932, 2024 (SCI-Expanded, Scopus)

8. Comparison of focal segmental glomerulosclerosis and other primary glomerulonephrites in terms of parameters of hepatic steatosis and metabolic syndrome

Ozkan E., GÖK M., Cetinkaya H., KAPLAN M., ŞAHİN G.
International Urology and Nephrology , cilt.55, sa.10, ss.2557-2566, 2023 (SCI-Expanded, Scopus)

9. The Longitudinal Evolution of Post–COVID-19 Outcomes Among Hemodialysis Patients in Turkey

Ozturk S., Turgutalp K., ARICI M., GÖRGÜLÜ N., Tonbul H. Z., EREN N., et al.
Kidney International Reports , cilt.7, sa.6, ss.1393-1405, 2022 (SCI-Expanded, Scopus)

10. Methaemoglobinaemia in pregnancy with chronic kidney disease an uncommon case: A case report

GÖK M., Aydemir Y. G.
Journal of the Pakistan Medical Association , cilt.72, sa.2, ss.363-365, 2022 (SCI-Expanded, Scopus)

11. Evaluation of the relationship between the mean platelet volume and the neutrophil/lymphocyte ratio with progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease

GÖK M.
Northern Clinics of Istanbul , cilt.9, sa.4, ss.317-322, 2022 (ESCI, Scopus, TRDizin)

12. Plasma sTWEAK levels in chronic kidney disease stages Niveles plasmáticos de sTWEAK en estadios de enfermedad renal crónica

GÖK M., Cetinkaya H., OĞUZ Y.
Revista de Nefrologia, Dialisis y Trasplante , cilt.42, sa.2, ss.103-108, 2022 (SCI-Expanded, Scopus)

13. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

Ozturk S., Turgutalp K., ARICI M., GÖK M., Islam M., ALTIPARMAK M. R., et al.
International Journal of Clinical Practice , cilt.75, sa.9, 2021 (SCI-Expanded, Scopus)

14. Chronic kidney disease predicts poor outcomes of COVID-19 patients

GÖK M., Cetinkaya H., Kandemir T., Karahan E., Tuncer İ. B., Bukrek C., et al.
International Urology and Nephrology , cilt.53, sa.9, ss.1891-1898, 2021 (SCI-Expanded, Scopus)

15. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology

Arikan H., Ozturk S., TOKGÖZ B., Dursun B., SEYAHİ N., TRABULUS S., et al.
PLoS ONE , cilt.16, sa.8 August, 2021 (SCI-Expanded, Scopus) Creative Commons License

16. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group

ŞUMNU A., Turkmen K., CEBECİ E., Turkmen A., EREN N., SEYAHİ N., et al.
International Urology and Nephrology , cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded, Scopus)

17. The collapsing variant of focal segmental glomerulosclerosis (FSGS) secondary to sarcoidosis, a very rare case

GÖK M., Ayten O., Onur O., Cetinkaya H., GÜMRÜKÇÜ G., ŞAHİN G.
Iranian Journal of Kidney Diseases , cilt.15, sa.1, ss.64-68, 2021 (SCI-Expanded, Scopus)

18. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey

ÖZTÜRK S., Turgutalp K., ARICI M., Odabas A. R., ALTIPARMAK M. R., AYDIN Z., et al.
Nephrology Dialysis Transplantation , cilt.35, sa.12, ss.2083-2095, 2021 (SCI-Expanded, Scopus)

19. Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group

Turkmen A., ŞUMNU A., CEBECİ E., Yazici H., EREN N., SEYAHİ N., et al.
BMC Nephrology , cilt.21, sa.1, 2020 (SCI-Expanded, Scopus)

20. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease

Solak Y., Yilmaz M. I., Siriopol D., Saglam M., Unal H. U., Yaman H., et al.
International Urology and Nephrology , cilt.47, sa.12, ss.1993-2001, 2015 (SCI-Expanded, Scopus)

21. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease

Sonmez A., Yilmaz M. I., Saglam M., Unal H. U., GÖK M., Cetinkaya H., et al.
Lipids in Health and Disease , cilt.14, sa.1, 2015 (SCI-Expanded, Scopus)

22. A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation

Yilmaz M. I., Sonmez A., Saglam M., Cayci T., Kilic S., Unal H. U., et al.
Clinical Journal of the American Society of Nephrology , cilt.10, sa.3, ss.471-479, 2015 (SCI-Expanded, Scopus)

23. Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy

Yilmaz M. I., Sonmez A., Saglam M., Kurt Y. G., Unal H. U., Karaman M., et al.
American Journal of Nephrology , cilt.40, sa.3, ss.208-214, 2014 (SCI-Expanded, Scopus)

24. Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease

Unal H. U., ÇELİK M., Gökoʇlan Y., Çetinkaya H., GÖK M., Karaman M., et al.
Renal Failure , cilt.36, sa.10, ss.1481-1485, 2014 (SCI-Expanded, Scopus)

25. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients

Kanbay M., Siriopol D., Saglam M., Kurt Y. G., GÖK M., Cetinkaya H., et al.
Journal of Clinical Endocrinology and Metabolism , cilt.99, sa.10, 2014 (SCI-Expanded, Scopus)

26. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease

Kanbay M., Solak Y., Unal H. U., Kurt Y. G., GÖK M., Cetinkaya H., et al.
International Urology and Nephrology , cilt.46, sa.8, ss.1619-1625, 2014 (SCI-Expanded, Scopus)

27. Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events

Yilmaz M. I., Demirkaya E., Acikel C., Saldir M., Akar S., Cayci T., et al.
Rheumatology (United Kingdom) , cilt.53, sa.11, ss.2002-2008, 2014 (SCI-Expanded, Scopus)

28. The importance of immuneofluorescence staining in patients with primary FSGS

Ünal H. U., Çakar M., Yavan I., Kiliç S., Özcan A., Yilmaz M. I., et al.
Turkish Nephrology, Dialysis and Transplantation Journal , cilt.23, sa.1, ss.51-55, 2014 (Scopus, TRDizin)

29. The importance of serum CXCL-16 levels in patients with grade III-V Chronic Kidney Disease

Ünal H. U., Kurt Y. G., GÖK M., Çetinkaya H., Karaman M., Eyileten T., et al.
Turkish Nephrology, Dialysis and Transplantation Journal , cilt.23, sa.3, ss.234-239, 2014 (Scopus, TRDizin)

30. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease

Yilmaz M. I., Siriopol D., Saglam M., Kurt Y. G., Unal H. U., Eyileten T., et al.
Kidney International , cilt.86, sa.6, ss.1213-1220, 2014 (SCI-Expanded, Scopus)

31. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease

Solak Y., Yilmaz M. I., Saglam M., Caglar K., Verim S., Unal H. U., et al.
American Journal of the Medical Sciences , cilt.347, sa.2, ss.118-124, 2014 (SCI-Expanded, Scopus)

32. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Unal H. U., GÖK M., et al.
European Journal of Clinical Investigation , cilt.43, sa.12, ss.1250-1257, 2013 (SCI-Expanded, Scopus)

33. A rare cause of post-exercise acute renal failure: Renal hipouricemia Egzersi̇z sonrasi akut böbrek yetmezli̇ǧi̇ni̇n nadi̇r bi̇r nedeni̇: Renal hi̇poüri̇semi̇

Ünal H. U., Çakar M., GÖK M., Yilmaz M. I., Eyileten T., Çaǧlar K., et al.
Anatolian Journal of Clinical Investigation , cilt.7, sa.4, ss.225-227, 2013 (Scopus)

34. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease

Solak Y., Yilmaz M. I., Sonmez A., Saglam M., Cakir E., Unal H. U., et al.
Clinical and Experimental Nephrology , cilt.17, sa.4, ss.532-540, 2013 (SCI-Expanded, Scopus)

35. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease

Yilmaz M. I., TURGUT F. H., Kanbay M., Saglam M., Sonmez A., Yaman H., et al.
International Urology and Nephrology , cilt.45, sa.4, ss.1071-1078, 2013 (SCI-Expanded, Scopus)

36. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides

GÖK M., ERDEM H., GÖĞÜŞ F. N., YILMAZ S., KARADAĞ Ö., Simsek I., et al.
Rheumatology International , cilt.33, sa.4, ss.879-885, 2013 (SCI-Expanded, Scopus)

37. Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Kilic S., Turker T., et al.
American Journal of Nephrology , cilt.37, sa.2, ss.126-134, 2013 (SCI-Expanded, Scopus)

38. Serum calcitonin and endothelial dysfunction in chronic kidney disease: A novel risk factor?

Kanbay M., Yilmaz M. I., Afsar B., Saglam M., Akgul E. O., Cayci T., et al.
International Urology and Nephrology , cilt.45, sa.1, ss.151-156, 2013 (SCI-Expanded, Scopus)

39. Renal cell carcinoma in a transplanted kidney after 29 years: A case report and review of the literature Transplante Böbrekte 29 yil Sonra Renal Hücreli Karsinoma: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Ünal H. U., GÖK M., Yilmaz M. I., Eyileten T., Çaǧlar K., OĞUZ Y., et al.
Turkish Nephrology, Dialysis and Transplantation Journal , cilt.21, sa.3, ss.295-297, 2012 (Scopus, TRDizin)

40. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients

Kanbay M., Yilmaz M. I., Apetrii M., Saglam M., Yaman H., Unal H. U., et al.
American Journal of Nephrology , cilt.36, sa.3, ss.228-237, 2012 (SCI-Expanded, Scopus)

41. The spitzer-weinstein syndrome: One form of type IV renal tubular acidosis and its response to indapamide: A case report Spitzer-weinstein sendromu: Tip 4 renal tubuler asidozun bir formu ve i̇ndapamide cevabi: Bir olgu sunumu

Ünal H. U., GÖK M., Yilmaz M. I., Eyileten T., OĞUZ Y., Çaǧlar K., et al.
Turkish Nephrology, Dialysis and Transplantation Journal , cilt.21, sa.2, ss.201-204, 2012 (Scopus, TRDizin)

42. Findings of biopsy-proven chronicity and end-stage renal failure associated with oral sodium phosphate solution

Cakar M., Kanbay M., Sarlak H., Akhan M., GÖK M., Unal H. U., et al.
Renal Failure , cilt.34, sa.4, ss.499-501, 2012 (SCI-Expanded, Scopus)

43. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD

Carrero J. J., Kyriazis J., Sonmez A., Tzanakis I., Qureshi A. R., Stenvinkel P., et al.
Clinical Journal of the American Society of Nephrology , cilt.7, sa.2, ss.207-215, 2012 (SCI-Expanded, Scopus)

44. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome

Genc H., Dogru T., Tapan S., Tasci I., Bozoglu E., GÖK M., et al.
Clinical Biochemistry , cilt.45, sa.1-2, ss.92-95, 2012 (SCI-Expanded, Scopus)

45. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease

Yilmaz M. I., Sonmez A., Qureshi A. R., Saglam M., Stenvinkel P., Yaman H., et al.
Clinical Journal of the American Society of Nephrology , cilt.6, sa.7, ss.1617-1625, 2011 (SCI-Expanded, Scopus)

46. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

Dogru T., Sonmez A., Tasci I., Bozoglu E., Yilmaz M. I., Genc H., et al.
Diabetes Research and Clinical Practice , cilt.76, sa.1, ss.24-29, 2007 (SCI-Expanded, Scopus)

47. Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose

Tasci I., Dogru T., Sonmez A., Genc H., Kilic S., Olgun A., et al.
Mediators of Inflammation , cilt.2006, 2006 (SCI-Expanded, Scopus)

48. The plasma levels of soluble P-selectin in subjects with prediabetes

Dogru T., Tasci I., Sonmez A., Genc H., GÖK M., Yilmaz M., et al.
International Journal of Clinical Practice , cilt.60, sa.9, ss.1048-1052, 2006 (SCI-Expanded, Scopus)
Metrikler

Yayın

48

Yayın (WoS)

47

Yayın (Scopus)

48

H-İndeks (WoS)

19

Atıf (Scopus)

1797

H-İndeks (Scopus)

19

Tez Danışmanlığı

2

Açık Erişim

4